Pacific Edge shares tumble 14% after FY net loss

Pacific Edge shares tumble 14% after FY net loss
Rebecca Howard
By Rebecca Howard May 29 (BusinessDesk) - Pacific Edge's shares fell 14 percent, despite reporting a smaller full year net loss as more people adopted its Cxbladder cancer diagnostics tests. The shares dropped to 18.5 cents after the Dunedin-based company reported a loss of $17.9 million in the year to March 31, versus a loss of $19.7 million in the prior year. Operating revenue from test sales was up 12 percent to $3.8 million while total revenue was up 3 percent to $5.1 million.  The company has developed non-invasive, accurate and s...

More Services

Sharesies founders sell down
Markets

Sharesies founders sell down

Global tech investor Rahul Mehta appears in Companies Office filings for the first time.

Pattrick Smellie 05 Nov 2025
Latest cap raise values Sharesies at $750m
Markets

Latest cap raise values Sharesies at $750m

In its eighth raise since 2017, Sharesies values its shares at $205 apiece.

Pattrick Smellie 10 Oct 2025
Two MC partners quit for specialist firm
Services

Two MC partners quit for specialist firm

Cuncannon now has a broader commercial offering. 

Staff reporters 06 Oct 2025
DB Breweries appoints new MD
Retail

DB Breweries appoints new MD

Peter Hart returns to NZ.

Victoria Young 01 Oct 2025